Most popular research briefings of 2018

Research briefings, published in 
Clinical Pharmacist
, are bite-sized articles, which keep our readers up to date with the latest developments in science and clinical research — from promising new treatments to discoveries involving already well-known drugs. In 2018, our most popular research briefings covered new areas of research that have been particularly topical this year — including medical cannabis, new antibiotics and e-cigarettes — as well as areas that have long been of interest to pharmacists, such as pain management and adherence. Take a look at our top ten most-read research briefings to refresh yourself on the science and clinical research that has been published this year, and check out articles still popular from 2017.

Top ten most read research briefings from 2018

1. Some ibuprofen users exceed daily NSAID dose limit
2. ACEIs linked to increased risk of lung cancer
3. Proton pump inhibitor lansoprazole might be effective against tuberculosis
4. Ibuprofen and paracetamol as effective for extremity pain as opioid combinations
5. Researchers find that e-cigarette fluid becomes more toxic during vaping
6. HPV infection increases risk of reinfection, study finds
7. New drug could reduce symptoms of gluten exposure in people with coeliac disease
8. Longest follow-up of HPV vaccination shows enduring protection after 10 years
9. Medical cannabis helps manage concurrent cancer-related symptoms
10. New antibiotic effective against multi-drug resistant Gram-negative UTI

Still popular from 2017

1. Magic mushrooms as a treatment for depression
2. Benefit of steroids for sore throat still unclear
3. ADHD drug shows promise for treating dyslexia
4. Botox more effective than topiramate for chronic migraine prevention
5. Diazepam should not be added to NSAIDs for acute lower back pain, researchers say